China Meheco Group Co

China Meheco Group Co EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of China Meheco Group Co (600056.SS) as of Oct 19, 2026 is 1.17 B CNY. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was 1.46 B CNY — a change of -19.31% (lower).

EBITDA

1.17 BCNY

YoY

-19.31%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of China Meheco Group Co is 2025 1.17 B CNY. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of China Meheco Group Co was 2024 1.46 B CNY. It decreases by -19.31% lower compared to the previous year.

The China Meheco Group Co EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2018
1.97 B CNY
Jan 1, 2019
1.95 B CNY
Jan 1, 2020
2.05 B CNY
Jan 1, 2021
1.55 B CNY
Jan 1, 2022
1.44 B CNY
Jan 1, 2023
2.01 B CNY
Jan 1, 2024
1.46 B CNY
Jan 1, 2025
1.17 B CNY
The China Meheco Group Co EBITDA history
YEAREBITDAYoY
1.17 BCNY-19.31%
1.46 BCNY-27.45%
2.01 BCNY+39.78%
1.44 BCNY-7.46%
1.55 BCNY-24.21%
2.05 BCNY+5.10%
1.95 BCNY-0.89%
1.97 BCNY-7.18%
2.12 BCNY+39.49%
1.52 BCNY+50.66%
1.01 BCNY+22.38%
823.32 MCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

China Meheco Group Co Stock analysis

What does China Meheco Group Co do? China Meheco Group Co Ltd is a healthcare company based in Beijing, China, operating within the healthcare sector. The company has been publicly traded since May 15, 1997, with its stock listed under the ticker 600056.SS and ISIN CNE000000Q29. It employs 8,313 full-time staff. China Meheco Group engages in the wholesale distribution of medicines, drugs, and Chinese herbal medicine. The company's operations are structured into three main segments: Industrial Pharmaceutical, Commercial Pharmaceutical, and Trading. The Industrial Pharmaceutical segment focuses on the manufacturing and distribution of chemical preparations, chemical bulk drugs, biological products, Chinese patent medicine, and herbal decoction pieces. The Commercial Pharmaceutical segment handles the wholesale and distribution of pharmaceuticals and medical devices. The Trading segment is involved in international exporting and the introduction of medical resources. The company maintains a website at http://www.meheco.com for further information. China Meheco Group operates within the healthcare industry, contributing to the pharmaceutical supply chain in China and beyond through its diversified business segments. China Meheco Group Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about China Meheco Group Co stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of China Meheco Group Co is 1.17 B CNY in 2025.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of China Meheco Group Co changed from 1.46 B CNY to 1.17 B CNY, representing a -19.31% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) China Meheco Group Co since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s China Meheco Group Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — China Meheco Group Co

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — China Meheco Group Co